About Lamed
Lamed is a Healthcare company based in Oberhaching (Germany) founded in 1989 by Lazaros Ayvatoglou, and was acquired by Translumina in June 2023. Endovascular solutions for thoracic aortic dissections are developed. Lamed offers products and services including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices.
Company details
The company was founded in 1989 and is based in Oberhaching, Germany. Endovascular solutions are developed for thoracic aortic dissections, aneurysms, and related conditions. Products such as the Ankura TAA stent graft system and the Peri-guard repair patch are included in the portfolio. Operations focus on medical device innovation within the cardiovascular sector, with distribution across Europe.
- Headquarters Oberhaching, Germany
- Founders Lazaros Ayvatoglou
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website lamed.de
- Social LinkedIn Facebook YouTube
- Acquired by Translumina (Jun 2023)
- Investors
- Acquired byTranslumina
(Jun 2023)
Products & Services of Lamed
Lamed offers a comprehensive portfolio of products and services, including Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse.
System for treating thoracic aortic dissections and aneurysms via endovascular methods.
Acellular patch used in vascular surgery for tissue reinforcement.
Steerable sheath for precise occluder placement in procedures.
Introduction sheath optimized for endovascular access in surgeries.
Apps and channels of Lamed
its YouTube channel Lamed GmbH has 35 subscribers.
Investors in Lamed
Lamed has secured backing from 1 investor. Prominent investors backing the company include Translumina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of drug-eluting stents and cardiovascular devices. It produces drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories. The company operates advanced manufacturing facilities and is committed to delivering high-quality products. Its focus is on developing and providing innovative cardiovascular intervention technologies. The manufacturing processes adhere to rigorous international standards. | 2010 | translumina.com | Hechingen, Germany |
Investor details for Lamed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lamed
1 people are tracked at Lamed (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lazaros Ayvatoglou | Founder & Owner | Leadership |
Complete people profiles for Lamed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lamed
2 dated milestones of Lamed across 34 years, from founding to its latest funding, stage changes and deals.
- Founded Lamed is founded.
- Exit Acquired by Translumina.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lamed
Complete news archive for Lamed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lamed
Lamed was founded in 1989.
Lamed is headquartered in Oberhaching, Germany. It is registered at Oberhaching, Bavaria, Germany.
The company was founded in 1989 and is based in Oberhaching, Germany. Endovascular solutions are developed for thoracic aortic dissections, aneurysms, and related conditions. Products such as the Ankura TAA stent graft system and the Peri-guard repair patch are included in the portfolio. Operations focus on medical device innovation within the cardiovascular sector, with distribution across Europe.
Lamed offers Ankura TAA Stent Graft System, Vascu-Guard, Fustar Steuerbare Schleuse, and H.Q.S Schleuse.
Lamed has 1 investor. Key investors include Translumina.
Yes. Lamed was acquired by Translumina in June 2023.